Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Truvian Appoints Renowned Physician-Scientist and Diagnostic Innovator Dr. Michael Mina as Chief Medical and Strategy Officer

Truvian Appoints Renowned Physician-Scientist and Diagnostic Innovator Dr. Michael Mina as Chief Medical and Strategy Officer

Indeterminate Rutland Herald - Vermont
Owner: George “Scoop” Sample
Volastra Therapeutics Expands Clinical Development Program Following Encouraging KIF18A Inhibitor Data and Appoints New Chief Medical Officer to Lead Clinical Strategy

Volastra Therapeutics Expands Clinical Development Program Following Encouraging KIF18A Inhibitor Data and Appoints New Chief Medical Officer to Lead Clinical Strategy

Indeterminate Rutland Herald - Vermont
Owner: George “Scoop” Sample
Science National Geographic How scientists learn from the masters of invisibility: Octopus

Science National Geographic How scientists learn from the masters of invisibility: Octopus

Science USA TODAY NASA plans 2 January spacewalks at ISS. Here's what to know, how to watch

Science USA TODAY NASA plans 2 January spacewalks at ISS. Here's what to know, how to watch

The REAL Da Vinci code: Scientists recover DNA from a Leonardo da Vinci drawing - and it could shed light on his genius

The REAL Da Vinci code: Scientists recover DNA from a Leonardo da Vinci drawing - and it could shed light on his genius

Polish biotech JPP Biologics reports positive Phase I data for first-in-class biologic for immune diseases

Polish biotech JPP Biologics reports positive Phase I data for first-in-class biologic for immune diseases

New Edition of Seminal Text "Solid-State Materials in Pharmaceutical Chemistry" Released by Industry Leaders

Amgen selects German Disco Pharma to collaborate in multi-million-dollar deal

Amgen selects German Disco Pharma to collaborate in multi-million-dollar deal

Frost & Sullivan Released the Report: How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control

From Rare Pigment to Industrial Bioproduct: How Engineered Microbes Are Boosting Violacein Production

From Rare Pigment to Industrial Bioproduct: How Engineered Microbes Are Boosting Violacein Production

Forlong Biotechology Announced Activation of Phase Ib/II Study of FL115 (IL-15 Superagonist) in combination with anti-PD-1 Antibody for Patients with Advanced Solid Tumor and Acceptance of IND for FL115 Subcutaneous Injection by NMPA

Forlong Biotechology Announced Activation of Phase Ib/II Study of FL115 (IL-15 Superagonist) in combination with anti-PD-1 Antibody for Patients with Advanced Solid Tumor and Acceptance of IND for FL115 Subcutaneous Injection by NMPA

Indeterminate Rutland Herald - Vermont
Owner: George “Scoop” Sample
Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China

Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China

Indeterminate Rutland Herald - Vermont
Owner: George “Scoop” Sample
MoPH affirms commitment to supporting National Pharmaceutical Industry

MoPH affirms commitment to supporting National Pharmaceutical Industry

Gov't Propaganda The Peninsula
Owner: H.E. Sheikh Thani Bin Abdullah Al-Thani
MoPH affirms commitment to support national pharmaceutical industry

MoPH affirms commitment to support national pharmaceutical industry

Gov't Propaganda Qatar Tribune
Owner: Sheikh Hamad bin Jassim bin Jaber Al Thani
Science National Geographic How scientists learn from the masters of invisibility: Octopus

Science National Geographic How scientists learn from the masters of invisibility: Octopus

Science USA TODAY NASA plans 2 January spacewalks at ISS. Here's what to know, how to watch

Science USA TODAY NASA plans 2 January spacewalks at ISS. Here's what to know, how to watch

The REAL Da Vinci code: Scientists recover DNA from a Leonardo da Vinci drawing - and it could shed light on his genius

The REAL Da Vinci code: Scientists recover DNA from a Leonardo da Vinci drawing - and it could shed light on his genius

Polish biotech JPP Biologics reports positive Phase I data for first-in-class biologic for immune diseases

Polish biotech JPP Biologics reports positive Phase I data for first-in-class biologic for immune diseases

New Edition of Seminal Text "Solid-State Materials in Pharmaceutical Chemistry" Released by Industry Leaders

Amgen selects German Disco Pharma to collaborate in multi-million-dollar deal

Amgen selects German Disco Pharma to collaborate in multi-million-dollar deal

Frost & Sullivan Released the Report: How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control

From Rare Pigment to Industrial Bioproduct: How Engineered Microbes Are Boosting Violacein Production

From Rare Pigment to Industrial Bioproduct: How Engineered Microbes Are Boosting Violacein Production

Forlong Biotechology Announced Activation of Phase Ib/II Study of FL115 (IL-15 Superagonist) in combination with anti-PD-1 Antibody for Patients with Advanced Solid Tumor and Acceptance of IND for FL115 Subcutaneous Injection by NMPA

Forlong Biotechology Announced Activation of Phase Ib/II Study of FL115 (IL-15 Superagonist) in combination with anti-PD-1 Antibody for Patients with Advanced Solid Tumor and Acceptance of IND for FL115 Subcutaneous Injection by NMPA

Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China

Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China

MoPH affirms commitment to supporting National Pharmaceutical Industry

MoPH affirms commitment to supporting National Pharmaceutical Industry

MoPH affirms commitment to support national pharmaceutical industry

MoPH affirms commitment to support national pharmaceutical industry

Truvian Appoints Renowned Physician-Scientist and Diagnostic Innovator Dr. Michael Mina as Chief Medical and Strategy Officer

Truvian Appoints Renowned Physician-Scientist and Diagnostic Innovator Dr. Michael Mina as Chief Medical and Strategy Officer

Volastra Therapeutics Expands Clinical Development Program Following Encouraging KIF18A Inhibitor Data and Appoints New Chief Medical Officer to Lead Clinical Strategy

Volastra Therapeutics Expands Clinical Development Program Following Encouraging KIF18A Inhibitor Data and Appoints New Chief Medical Officer to Lead Clinical Strategy

Show More

Video Stories

YouTube video thumbnail: Canadian Scientists Discover new Galaxies That Defy Theory
Play
Canadian Scientists Discover new Galaxies That Defy Theory
YouTube video thumbnail: Why Ancient Egyptian Writing Is More Than Just Hieroglyphics
Play
Why Ancient Egyptian Writing Is More Than Just Hieroglyphics
YouTube video thumbnail: Humanoid Robots Deal Cards, Grab Groceries at CES 2026
Play
Humanoid Robots Deal Cards, Grab Groceries at CES 2026
YouTube video thumbnail: Nvidia Unveils AI Model for Self-Driving Cars
Play
Nvidia Unveils AI Model for Self-Driving Cars

Video Title

Press Releases

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions